Clinical Development of New TB Vaccines: Recent Advances and Next Steps
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Development of New TB Vaccines: Recent Advances and Next Steps
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-30
DOI
10.3389/fmicb.2019.03154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic accuracy of ESAT-6 free IGRA compared to QuantiFERON-TB Gold In-tube
- (2019) Elisa Nemes et al. CLINICAL INFECTIOUS DISEASES
- Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study
- (2019) Rebecca C Harris et al. Lancet Global Health
- A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
- (2019) Andrew J. Nunn et al. NEW ENGLAND JOURNAL OF MEDICINE
- One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
- (2019) Susan Swindells et al. NEW ENGLAND JOURNAL OF MEDICINE
- Temporal trends in the prevalence of Mycobacterium tuberculosis infection in South African adolescents
- (2019) E. W. Bunyasi et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Evaluating vaccination strategies for tuberculosis in endemic and non-endemic settings
- (2019) Marissa Renardy et al. JOURNAL OF THEORETICAL BIOLOGY
- IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure
- (2019) Lenette L. Lu et al. NATURE MEDICINE
- Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
- (2019) Adam Penn-Nicholson et al. PLOS MEDICINE
- The global prevalence of latent tuberculosis: a systematic review and meta-analysis
- (2019) Adam Cohen et al. EUROPEAN RESPIRATORY JOURNAL
- Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis
- (2019) Javeed A Shah et al. JOURNAL OF INFECTIOUS DISEASES
- Age-specific prevalence of TB infection among household contacts of pulmonary TB: Is it time for TB preventive therapy?
- (2019) Chandra Kumar Dolla et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Estimating the annual risk of infection with Mycobacterium tuberculosis among adolescents in Western Kenya in preparation for TB vaccine trials
- (2019) Videlis Nduba et al. BMC INFECTIOUS DISEASES
- Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial
- (2019) Michele Tameris et al. Lancet Respiratory Medicine
- Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2019) Dereck R. Tait et al. NEW ENGLAND JOURNAL OF MEDICINE
- Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis
- (2018) Sara Suliman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
- (2018) Elisa Nemes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stratification by interferon-γ release assay level predicts risk of incident TB
- (2018) Brita Askeland Winje et al. THORAX
- BCG vaccine: WHO position paper, February 2018 – Recommendations
- (2018) World Health Organization VACCINE
- Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial
- (2018) Adam Penn-Nicholson et al. Lancet Respiratory Medicine
- Dose Optimization of H56:IC31 Vaccine for TB Endemic Populations: A Double-Blind, Placebo-Controlled, Dose-Selection Trial
- (2018) Sara Suliman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- WHO preferred product characteristics for new vaccines against tuberculosis
- (2018) Lewis K Schrager et al. LANCET INFECTIOUS DISEASES
- Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2018) Olivier Van Der Meeren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospects for a vaccine to prevent HIV-related tuberculosis
- (2018) Elisa Nemes et al. Current Opinion in HIV and AIDS
- Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults
- (2018) Nagalingeswaran Kumarasamy et al. MEDICINE
- Observational study to estimate the changes in the effectiveness of bacillus Calmette–Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK
- (2017) Punam Mangtani et al. HEALTH TECHNOLOGY ASSESSMENT
- The duration of protection of school-aged BCG vaccination in England: a population-based case–control study
- (2017) Punam Mangtani et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models
- (2017) A. P. Tkachuk et al. PLoS One
- European strategy for vaccine development against infectious diseases
- (2017) Line Matthiessen et al. VACCINE
- Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis
- (2017) Nacho Aguilo et al. Nature Communications
- Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial
- (2017) Surendra K. Sharma et al. Scientific Reports
- Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study
- (2017) Jason R Andrews et al. Lancet Respiratory Medicine
- The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
- (2017) Natalie E. Nieuwenhuizen et al. Frontiers in Immunology
- Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901
- (2017) C. Fordham von Reyn et al. PLoS One
- Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons
- (2016) Timothy R. Sterling et al. AIDS
- Design of tuberculosis vaccine trials under financial constraints
- (2016) Alberto L. García-Basteiro et al. Expert Review of Vaccines
- Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans
- (2016) Mangalakumari Jeyanathan et al. JOURNAL OF INFECTIOUS DISEASES
- A blood RNA signature for tuberculosis disease risk: a prospective cohort study
- (2016) Daniel E Zak et al. LANCET
- A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults
- (2016) Nagalingeswaran Kumarasamy et al. MEDICINE
- Drug-resistant TB: deadly, costly and in need of a vaccine
- (2016) Janna Manjelievskaia et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Safety and immunogenicity of the M72/AS01 E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study
- (2016) Paul Gillard et al. TUBERCULOSIS
- Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines
- (2016) Rebecca C. Harris et al. Human Vaccines & Immunotherapeutics
- The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
- (2016) Rein M. G. J. Houben et al. PLOS MEDICINE
- Prevalence and risk factors of latent Tuberculosis among adolescents in rural Eastern Uganda
- (2015) D Mumpe-Mwanja et al. African Health Sciences
- Management of latentMycobacterium tuberculosisinfection: WHO guidelines for low tuberculosis burden countries
- (2015) Haileyesus Getahun et al. EUROPEAN RESPIRATORY JOURNAL
- WHO's new End TB Strategy
- (2015) Mukund Uplekar et al. LANCET
- Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study
- (2015) Lei Gao et al. LANCET INFECTIOUS DISEASES
- Innovative clinical trial designs to rationalize TB vaccine development
- (2015) R.D. Ellis et al. TUBERCULOSIS
- Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting
- (2015) Adam Penn-Nicholson et al. VACCINE
- Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysis
- (2015) Sabine Hermans et al. Journal of the International AIDS Society
- Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial
- (2015) François Spertini et al. Lancet Respiratory Medicine
- Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy
- (2014) Eleonora G. Thacher et al. AIDS
- The Temporal Dynamics of Relapse and Reinfection Tuberculosis After Successful Treatment: A Retrospective Cohort Study
- (2014) F. M. Marx et al. CLINICAL INFECTIOUS DISEASES
- Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette–Guérin vaccination against tuberculosis
- (2014) I Abubakar et al. HEALTH TECHNOLOGY ASSESSMENT
- Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients
- (2014) K. J. M. Aung et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
- (2014) Corinne S. Merle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
- (2014) Stephen H. Gillespie et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
- (2014) Amina Jindani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection
- (2014) Andre S. Nell et al. PLoS One
- Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries
- (2014) G. M. Knight et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis
- (2014) R. Y. Chen et al. Science Translational Medicine
- Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis
- (2014) A. Roy et al. BMJ-British Medical Journal
- Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults
- (2013) Cheryl L. Day et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
- (2013) Punam Mangtani et al. CLINICAL INFECTIOUS DISEASES
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
- (2013) Michele D Tameris et al. LANCET
- Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials
- (2013) Ainhoa Arbues et al. VACCINE
- Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium tuberculosis
- (2012) Jason R. Andrews et al. CLINICAL INFECTIOUS DISEASES
- Correction: Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
- (2012) Shama D. Ahuja et al. PLOS MEDICINE
- Non-specific effects of BCG?
- (2011) P. E. M. Fine et al. JOURNAL OF INFECTIOUS DISEASES
- Randomized Trial of BCG Vaccination at Birth to Low-Birth-Weight Children: Beneficial Nonspecific Effects in the Neonatal Period?
- (2011) Peter Aaby et al. JOURNAL OF INFECTIOUS DISEASES
- The Tuberculin Skin Test versus QuantiFERON TB Gold® in Predicting Tuberculosis Disease in an Adolescent Cohort Study in South Africa
- (2011) Hassan Mahomed et al. PLoS One
- Mycobacterium vaccae as Adjuvant Therapy to Anti-Tuberculosis Chemotherapy in Never-Treated Tuberculosis Patients: A Meta-Analysis
- (2011) Xiao-Yan Yang et al. PLoS One
- Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: Second report of the BCG-REVAC cluster-randomised trial
- (2011) Mauricio L. Barreto et al. VACCINE
- The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices
- (2011) Alice Zwerling et al. PLOS MEDICINE
- Prevention of tuberculosis in Bacille Calmette–Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine
- (2010) Charles F von Reyn et al. AIDS
- The second Geneva Consensus: Recommendations for novel live TB vaccines
- (2010) K.B. Walker et al. VACCINE
- Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa
- (2009) Stephen D Lawn et al. AIDS
- Disseminated bacille Calmette-Guerin disease in HIV-infected South African infants
- (2009) AC Hesseling BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
- (2009) L. J. Abu-Raddad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started